
 
 
  This drug entry is a  stub  and has not been fully annotated. It is scheduled to be annotated soon.  Identification Generic Name (1,2,6,7-3H)Testosterone DrugBank Accession Number DB14093 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1,2,6,7-3H)Testosterone (DB14093) ×  Close Weight Average: 296.463  Monoisotopic: 296.241827085  Chemical Formula C 19 H 28 O 2 Synonyms Testosterone, 1,2,6,7-H-3 Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Not Available Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Approved Vet approved Nutraceutical Illicit Withdrawn Investigational Experimental All Drugs Drug Interaction Integrate drug-drug  interactions in your software 
 
 
 Abciximab (1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Abciximab. Acenocoumarol (1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Acenocoumarol. Alteplase (1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Alteplase. Ancrod (1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Ancrod. Anistreplase (1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Anistreplase. Antithrombin Alfa (1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Antithrombin Alfa. Antithrombin III human (1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Antithrombin III human. Apixaban (1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Apixaban. Ardeparin (1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Ardeparin. Argatroban (1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Argatroban. Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Food Interactions Not Available Categories Drug Categories Testosterone and derivatives Classification Not classified Affected organisms Not Available Chemical Identifiers UNII P57HP4MCQZ CAS number 67308-98-9 InChI Key MUMGGOZAMZWBJJ-JQSYSRDDSA-N InChI InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1/i3T,4T,7T,9T/t3?,4?,7?,9?,14-,15-,16-,17-,18-,19- IUPAC Name (1S,3aS,3bR,9aR,9bS,11aS)-1-hydroxy-9a,11a-dimethyl(4,5,8,9-3H4)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one SMILES [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C([3H])C([3H])C2=CC(=O)C([3H])C([3H])[C@]12C References General References Not Available External Links ChemSpider 35147838 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0333 mg/mL ALOGPS logP 2.99 ALOGPS logP 3.37 Chemaxon logS -3.9 ALOGPS pKa (Strongest Acidic) 18.52 Chemaxon pKa (Strongest Basic) -0.88 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 37.3 Å 2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 84.43 m 3 ·mol -1 Chemaxon Polarizability 34.05 Å 3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Not Available Spectra Mass Spec (NIST) Not Available Spectra Not Available × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 18, 2018 17:59 / Updated at February 25, 2023 19:42 